Oxford Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,460
Closed -$359K 731
2025
Q3
$359K Buy
+6,460
New +$346K 0.12% 306
2025
Q2
Sell
-3,622
Closed -$212K 756
2025
Q1
$212K Buy
+3,622
New +$245K 0.1% 341
2019
Q3
Sell
-38,912
Closed -$2.03M 1947
2019
Q2
$2.03M Buy
38,912
+34,208
+727% +$1.72M 0.04% 636
2019
Q1
$233K Buy
+4,704
New +$212K 0.01% 1475
2018
Q4
Sell
-6,532
Closed -$333K 2096
2018
Q3
$333K Sell
6,532
-19,884
-75% -$881K 0.01% 1470
2018
Q2
$973K Sell
26,416
-8,228
-24% -$314K 0.02% 1051
2018
Q1
$1.31M Sell
34,644
-36,340
-51% -$1.28M 0.03% 803
2017
Q4
$2.29M Sell
70,984
-18,772
-21% -$596K 0.05% 504
2017
Q3
$2.71M Buy
89,756
+17,384
+24% +$516K 0.05% 459
2017
Q2
$2.13M Buy
72,372
+36,056
+99% +$985K 0.04% 582
2017
Q1
$923K Buy
+36,316
New +$937K 0.02% 842

Other funds holding TECH

Oxford Asset Management's TECH Position: Q4 2025 in Review

Oxford Asset Management sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 6,460 shares — an estimated $359K sold.

Oxford Asset Management first reported a position in TECH in Q1 2017 and held it in 11 quarters. The position peaked at $2.71M in Q3 2017. 584 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Oxford Asset Management reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • Oxford Asset Management sold 6,460 Bio-Techne shares in Q4 2025, an estimated $359K.
  • Oxford Asset Management first reported a position in Bio-Techne in Q1 2017 and held it in 11 quarters.
  • Oxford Asset Management's Bio-Techne position peaked at $2.71M in Q3 2017.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Oxford Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.